Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Partelli

Showing results (171-180 of 281) with videos related to

Pageof 29
Sort By:
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
Endocrine|July 10, 2025
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysisClaudio Ricci, Stefano Partelli, Davide Campana, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Endocrine Pathology|December 23, 2022
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine TumorsMarco Schiavo Lena, Stefano Partelli, Valentina Andreasi, et al.
European Radiology|December 22, 2022
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic featuresMartina Mori, Diego Palumbo, Francesca Muffatti, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.
The British Journal of Surgery|October 29, 2022
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomyNicolò Pecorelli, Diego Palumbo, Giovanni Guarneri, et al.
Advances in Therapy|October 13, 2025
The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert OpinionSalvatore Tafuto, Secondo Lastoria, Francesco Panzuto, et al.
Journal of Neuroendocrinology|November 2, 2023
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral centerValentina Andreasi, Stefano Partelli, Francesca Muffatti, et al.
Pageof 29

Showing results (171-180 of 281) with videos related to

Sort By:
Pageof 29
Annals of Surgical Oncology|January 24, 2022
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-MakingGiovanni Marchegiani, Stefano Crippa, Giampaolo Perri, et al.
Endocrine|July 10, 2025
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysisClaudio Ricci, Stefano Partelli, Davide Campana, et al.
Surgery|August 27, 2024
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrenceDomenico Tamburrino, Claudia Arcangeli, Federico De Stefano, et al.
Endocrine Pathology|December 23, 2022
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine TumorsMarco Schiavo Lena, Stefano Partelli, Valentina Andreasi, et al.
European Radiology|December 22, 2022
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic featuresMartina Mori, Diego Palumbo, Francesca Muffatti, et al.
Surgery|June 6, 2022
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fireFrancesca Aleotti, Stefano Crippa, Giulio Belfiori, et al.
Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.
The British Journal of Surgery|October 29, 2022
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomyNicolò Pecorelli, Diego Palumbo, Giovanni Guarneri, et al.
Advances in Therapy|October 13, 2025
The Role of Radioligand Therapy in Gastroenteropancreatic Neuroendocrine Tumors: An Italian Expert OpinionSalvatore Tafuto, Secondo Lastoria, Francesco Panzuto, et al.
Journal of Neuroendocrinology|November 2, 2023
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral centerValentina Andreasi, Stefano Partelli, Francesca Muffatti, et al.
Pageof 29